Kieran Haynes, Principal Consultant at Strativ Group, sat down with guest Nikhil Haas, Co-Founder of BioLM to discuss a wide variety of topics in AI Drug Discovery.
The focus was tied closely to Nikhil's work at BioLM; making AI accessible for biology and chemistry teams, deciding how to and when to use AI and ultimately demystifying where AI and Drug Discovery intersect.
","author_name":"Dan Wilkinson"}